Intelligent Cardioverter-Defibrillator (ICD) System with AI-Driven Arrhythmia Prediction
Legal Citation
Summary of the Inventive Concept
An implantable cardioverter-defibrillator (ICD) system integrated with artificial intelligence (AI), machine learning, and IoT technologies to predict and prevent arrhythmic events, enhancing patient outcomes and reducing healthcare costs.
Background and Problem Solved
The original patent provided an implantable cardioverter-defibrillator (ICD) system with a substernal pacing lead, but it lacked the ability to predict arrhythmic events and adapt therapy accordingly. This limitation resulted in suboptimal patient outcomes and increased healthcare costs. The new inventive concept addresses this limitation by integrating AI-driven arrhythmia prediction, enabling proactive and personalized cardiac therapy.
Detailed Description of the Inventive Concept
The intelligent ICD system comprises an implantable cardioverter-defibrillator (ICD) with a substernal pacing lead, a machine learning module, a communication module, and an artificial intelligence module. The machine learning module analyzes cardiac rhythm data from the ICD system and predicts arrhythmic events. The communication module transmits the prediction data to a remote server for further analysis and feedback. The artificial intelligence module adjusts the therapy parameters of the ICD system based on the analysis, providing personalized cardiac therapy. Additionally, the system may include a blockchain-based data storage module for secure data management and an IoT-based analytics platform for trend analysis and pattern identification.
Novelty and Inventive Step
The new inventive concept's integration of AI-driven arrhythmia prediction, machine learning, and IoT technologies with the original ICD system's substernal pacing lead constitutes a novel and non-obvious advancement. The inventive step lies in the synergistic combination of these distinct technologies, enabling proactive and personalized cardiac therapy.
Alternative Embodiments and Variations
Alternative embodiments may include integrating the AI-driven arrhythmia prediction module with other implantable cardiac devices, such as pacemakers or cardiac resynchronization therapy devices. Variations may include using different machine learning algorithms or incorporating additional data sources, such as genomic data or wearable device data, to enhance the accuracy of arrhythmia prediction.
Potential Commercial Applications and Market
The intelligent ICD system has significant commercial potential in the cardiac rhythm management market, with potential applications in hospitals, clinics, and remote patient monitoring settings. The system's ability to predict and prevent arrhythmic events can reduce healthcare costs, improve patient outcomes, and enhance the quality of life for individuals with cardiac conditions.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Technology - Implantable Cardiac Rhythm Management Systems, requiring advanced understanding of electrical engineering, biomedical engineering, signal processing, and medical device design with expertise in cardiovascular interventional technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 5-10 years experience in cardiac rhythm management technologies, familiar with implantable cardioverter-defibrillator systems, signal processing algorithms, and emerging medical technology integration techniques
Obviousness Rationale
A PHOSITA would recognize that integrating machine learning and AI technologies into existing ICD systems represents a predictable technological evolution, leveraging known signal processing techniques to enhance diagnostic and therapeutic capabilities. The fundamental substrate of cardiac rhythm monitoring remains consistent, with the PTD merely applying contemporary computational methods to improve existing medical device functionality. The proposed variations represent incremental improvements using standard engineering design approaches that would be apparent to a skilled practitioner in the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,779 |
|---|---|
| Title | Implantable cardioverter-defibrillator (ICD) system including substernal pacing lead |
| Assignee(s) | Medtronic, Inc. |